Dagna Constenla

1.8k total citations
55 papers, 1.1k citations indexed

About

Dagna Constenla is a scholar working on Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Dagna Constenla has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Health, 19 papers in Infectious Diseases and 16 papers in Epidemiology. Recurrent topics in Dagna Constenla's work include Vaccine Coverage and Hesitancy (20 papers), Global Maternal and Child Health (15 papers) and Viral gastroenteritis research and epidemiology (14 papers). Dagna Constenla is often cited by papers focused on Vaccine Coverage and Hesitancy (20 papers), Global Maternal and Child Health (15 papers) and Viral gastroenteritis research and epidemiology (14 papers). Dagna Constenla collaborates with scholars based in United States, United Kingdom and Colombia. Dagna Constenla's co-authors include Lynn Antil, Richard Rheingans, Bryan Patenaude, Logan Brenzel, So Yoon Sim, Elizabeth Watts, Bruce L. Innis, Thomas Breuer, Elisa Sicuri and María Teresa Valenzuela and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Dagna Constenla

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dagna Constenla United States 21 436 350 305 240 182 55 1.1k
Anita K. M. Zaidi Pakistan 20 423 1.0× 326 0.9× 359 1.2× 155 0.6× 250 1.4× 40 1.1k
Milagritos D. Tapia United States 20 512 1.2× 492 1.4× 171 0.6× 215 0.9× 254 1.4× 57 1.4k
Emily Wilson United States 10 299 0.7× 873 2.5× 474 1.6× 177 0.7× 143 0.8× 30 1.4k
Carsten Mantel Switzerland 15 261 0.6× 299 0.9× 297 1.0× 260 1.1× 190 1.0× 35 966
Fiona Braka Nigeria 16 267 0.6× 404 1.2× 328 1.1× 78 0.3× 86 0.5× 91 839
Michaela A. Riddell Australia 22 471 1.1× 635 1.8× 231 0.8× 190 0.8× 70 0.4× 65 1.4k
Robert Steinglass United States 16 292 0.7× 312 0.9× 565 1.9× 66 0.3× 201 1.1× 36 959
Sylvia Becker‐Dreps United States 26 1.0k 2.4× 519 1.5× 238 0.8× 228 0.9× 97 0.5× 107 1.8k
Richard Mihigo Republic of the Congo 20 459 1.1× 456 1.3× 585 1.9× 53 0.2× 148 0.8× 74 1.1k
Frank Mahoney United States 26 796 1.8× 879 2.5× 336 1.1× 240 1.0× 63 0.3× 53 2.0k

Countries citing papers authored by Dagna Constenla

Since Specialization
Citations

This map shows the geographic impact of Dagna Constenla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagna Constenla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagna Constenla more than expected).

Fields of papers citing papers by Dagna Constenla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagna Constenla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagna Constenla. The network helps show where Dagna Constenla may publish in the future.

Co-authorship network of co-authors of Dagna Constenla

This figure shows the co-authorship network connecting the top 25 collaborators of Dagna Constenla. A scholar is included among the top collaborators of Dagna Constenla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagna Constenla. Dagna Constenla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Constenla, Dagna, et al.. (2025). Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases. The Journal of Infectious Diseases. 232(6). e931–e940. 1 indexed citations
4.
Kiracho, Elizabeth Ekirapa, et al.. (2021). The economic burden of pneumonia in children under five in Uganda. Vaccine X. 8. 100095–100095. 11 indexed citations
5.
Ahmed, Sayem, et al.. (2020). The economic burden of measles in children under five in Bangladesh. BMC Health Services Research. 20(1). 7 indexed citations
7.
Sim, So Yoon, Mark Jit, Dagna Constenla, David H. Peters, & Raymond Hutubessy. (2019). A Scoping Review of Investment Cases for Vaccines and Immunization Programs. Value in Health. 22(8). 942–952. 10 indexed citations
8.
Haidari, Leila A., Shawn T. Brown, Dagna Constenla, et al.. (2017). Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique. Sexually Transmitted Diseases. 44(4). 222–226. 5 indexed citations
9.
Haidari, Leila A., Shawn T. Brown, Dagna Constenla, et al.. (2016). The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique. Vaccine. 34(35). 4161–4165. 10 indexed citations
10.
Constenla, Dagna. (2015). Post-introduction economic evaluation of pneumococcal conjugate vaccination in Ecuador, Honduras, and Paraguay.. PubMed. 38(5). 388–95. 11 indexed citations
11.
Martelli, Celina Maria Turchi, João Bosco Siqueira, Ana Laura de Sene Amâncio Zara, et al.. (2015). Economic Impact of Dengue: Multicenter Study across Four Brazilian Regions. PLoS neglected tropical diseases. 9(9). e0004042–e0004042. 72 indexed citations
13.
Patel, Hiten D., Eric T. Roberts, & Dagna Constenla. (2013). Cost-effectiveness of a new rotavirus vaccination program in Pakistan: A decision tree model. Vaccine. 31(51). 6072–6078. 14 indexed citations
14.
Constenla, Dagna, et al.. (2013). Expert consensus-building for developing guidelines: lessons learned from a dengue economics workshop.. PubMed. 34(3). 198–203. 2 indexed citations
15.
Constenla, Dagna, F. Raúl Velázquez, Richard Rheingans, Lynn Antil, & Yolanda Cervantes. (2009). Economic impact of a rotavirus vaccination program in Mexico. Revista Panamericana de Salud Pública. 25(6). 481–490. 27 indexed citations
16.
Constenla, Dagna, Alexandre C. Linhares, Richard Rheingans, et al.. (2009). Economic Impact of a Rotavirus Vaccine in Brazil. Journal of Health Population and Nutrition. 26(4). 388–96. 39 indexed citations
17.
Sinha, Anushua, Dagna Constenla, Rosalyn O’Loughlin, et al.. (2008). Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis. Revista Panamericana de Salud Pública. 24(5). 304–313. 49 indexed citations
18.
Constenla, Dagna, et al.. (2007). Evaluación del impacto económico de la vacuna antirrotavírica en Venezuela. 46(1). 12–23. 6 indexed citations
19.
Rheingans, Richard, Dagna Constenla, Lynn Antil, Bruce L. Innis, & Thomas Breuer. (2007). Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries. Revista Panamericana de Salud Pública. 21(4). 192–204. 50 indexed citations
20.
Constenla, Dagna, et al.. (2006). Evaluación del impacto económico de la vacuna antirrotavírica en Venezuela. Revista Panamericana de Salud Pública. 20(4). 213–222. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026